From: Patients’ knowledge and beliefs concerning gout and its treatment: a population based study
Demographics | Total N = 240 | Active gout N = 53 | Inactive gout N = 187 | P value |
---|---|---|---|---|
Age (N and%) | 0.016 | |||
<65 | 81 (34) | 12 (23) | 69 (37) | |
65-74 | 93 (39) | 17 (32) | 76 (41) | |
75 or older | 66 (28) | 24 (45) | 42 (22) | |
Gender (% male) | 193 (80) | 37 (70) | 156 (83) | 0.028 |
Race (N and%) | 0.825 | |||
Caucasian | 225 (94) | 50 (94) | 175 (94) | |
Native American | 9 (4) | 2 (4) | 7 (4) | |
Hispanic | 3 (1) | 1 (2) | 2 (1) | |
Black | 2 (1) | 0 (0) | 2 (1) | |
Asian | 1 (0) | 0 (0) | 1 (1) | |
Highest grade completed (N and%) | 0.331 | |||
No high school degree | 33 (14) | 9 (18) | 24 (13) | |
High school graduate | 86 (36) | 19 (37) | 67 (36) | |
College | 118 (50) | 23 (45) | 95 (51) | |
Health Behaviors | ||||
Current smoking (N and%) | 13 (5) | 3 (6) | 10 (5) | 0.929 |
Alcohol use* (N and%) | 94 (39) | 13 (25) | 81 (43) | 0.014 |
Associated Conditions | ||||
Dyslipidemia (N and%) | 196 (82) | 45 (85) | 151 (82) | 0.581 |
Hypertension (N and%) | 185 (78) | 44 (83) | 141 (76) | 0.295 |
Diabetes mellitus (N and%) | 91 (38) | 22 (42) | 69 (37) | 0.579 |
Coronary heart disease (N and%) | 77 (32) | 21 (40) | 56 (30) | 0.200 |
Renal disease (N and%) | 43 (18) | 12 (23) | 31 (17) | 0.327 |
Peripheral arterial disease (N and%) | 21 (9) | 8 (15) | 13 (7) | 0.069 |
Nephrolithiasis (N and%) | 17 (7) | 4 (8) | 13 (7) | 0.897 |
Gout history | ||||
Gout encounters (mean, ± SD)** | 1 (2) | 2 (3) | 1 (2) | |
Cared for by a rheumatologist (N and%) | 14 (6) | 8 (19) | 6 (4) | |
ULD dispensing (N and%) ** | 108 (47) | 37 (70) | 77 (42) | 0.0004 |
Colchicine use (N and%)** | 59 (26) | 23 (43) | 37 (21) | 0.0011 |
Glucocorticoid use (N and%)** | 44 (19) | 19 (36) | 26 (14) | 0.0005 |
NSAID use (N and%)** | 72 (32) | 14 (26) | 60 (33) | 0.355 |